Cooley-Led Biotech Prices IPO Low As More Companies Delay
Biotechnology firm Vera Therapeutics Inc. went public Friday after completing a $48 million initial public offering that priced well below its estimated range, represented by Cooley LLP, amid a rocky market...To view the full article, register now.
Already a subscriber? Click here to view full article